Medical Care Technologies Inc (ID) (MDCE)

Yes, that is why I asked about the consigned items. Then whatever percentage of profit on owned items is up in the air. Could make a double, or could loose money.

Important to remember he owns some of these auction items outright, not sure what his percentage is on consignment items. 

Sorry if I've forgotten or missed it, but does anyone know what percentage he gets of consigned items.
Wondering because he touts numbers, but unless he owns the items, I figure he's looks at 15-20% of that $150K.

Medical Care Technologies Subsidiary Infinite Auctions Surges Past $158,000 in High-Profile Memorabilia Auction with Explosive Viewer Engagement

Iconic LeBron, Kobe, and Iverson Game Worn Items Headline Event Generating Non-Dilutive Capital for Operations and Technology Development

MESA, AZ / ACCESS Newswire / July 8, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today highlighted powerful momentum at its wholly-owned subsidiary Infinite Auctions, where the ongoing summer memorabilia auction has already reached $158,478.02 in total value with over 82,500 views and more than two weeks remaining until the July 25 close.

The auction features standout iconic items, including a LeBron James record milestone jersey with a current bid of $42,500, a pair of Kobe Bryant 2001 NBA Finals game-worn sneakers at $25,000, and an Allen Iverson jersey with a current bid of $20,000. Proceeds from the company's owned inventory are designated to bolster operations and support the advancement of Medical Care Technologies' AI vision-based initiatives. This builds on more than $250,000 already generated through prior memorabilia sales.

"Infinite Auctions continues to demonstrate the strength of our diversified business model," said Marshall Perkins, CEO of Medical Care Technologies. "We are not simply an idea-stage entity - we are executing with real revenue-generating assets that directly support our broader technology portfolio."

The new in house developed website and proprietary in-house auction software platform recently launched by Infinite Auctions are enhancing user experience and driving engagement. This operational strength complements the company's ongoing development of its MDCE Melanoma Beta Scan technology.

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (OTC PINK:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company also owns subsidiaries Infinite Auctions and Real Game Used, which provide complementary revenue-generating operations. Visit: https://medicalcaretechnologies.com

About Infinite Auctions

Infinite Auctions is a wholly-owned subsidiary of Medical Care Technologies Inc. specializing in premium sports memorabilia auctions through its innovative online platform. Visit: https://infiniteauctions.com

Safe Harbor Statement:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information:

Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204 Phone: +1 (480) 645-0750

Email: info@infiniteauctions.com

Websites: https://medicalcaretechnologies.com | https://infiniteauctions.com

SOURCE: Medical Care Technologies Inc.


View the original press release on ACCESS Newswire

© Copyright 2026 ACCESS Newswire. All Rights Reserved.

Strong day. 1 share traded all day. Looking good

Medical Care Technologies, Inc. (OTC Pink:MDCE) Details Six-Phase Internal Testing Protocol Driving Melanoma Scan Beta Progress

Medical Care Technologies, Inc. (OTC PINK:MDCE) Details Six-Phase Internal Testing Protocol Driving Melanoma Scan Beta Progress

MESA, AZ / ACCESS Newswire / July 7, 2026 / Medical Care Technologies, Inc. (OTC PINK:MDCE) today elaborated on the rigorous six-phase internal testing framework that has powered the encouraging results announced on June 26, 2026.

Following the initial structured testing announcement on June 12, 2026, the Company has implemented a comprehensive, multi-stage internal evaluation process focused on training and optimizing its proprietary AI vision models for the MDCE Melanoma Scan Beta platform.

The six-phase internal testing protocol includes:

Dataset Ingestion & Preprocessing - Systematic curation and augmentation of diverse dermatoscopic images drawn from leading public benchmarks, including the HAM10000 dataset (~1,113 melanoma cases), the expansive ISIC Archive, and relevant TCIA melanoma collections.

Baseline Model Training - Initial training of the Company's proprietary computer vision and deep learning algorithms on balanced data subsets.

Hyperparameter Optimization & Cross-Validation - Rigorous fine-tuning and k-fold cross-validation to enhance model generalizability.

Simulated Real-World Stress Testing - Evaluation under varied lighting conditions, angles, skin tones, and lesion presentations to simulate real-world use.

Longitudinal Consistency & Monitoring - Testing of image organization, tracking, and longitudinal analysis capabilities essential for ongoing skin health monitoring.

Final Validation & Benchmarking- Independent internal review confirming performance metrics slightly above typical industry benchmarks for AI-powered skin lesion analysis tools (sensitivity typically 78-86% and specificity 75-88%).

These early results highlight meaningful improvements in image consistency, workflow efficiency, and preliminary detection accuracy, further validating the core technology.

"This structured six-phase approach ensures our AI models are robust, generalizable, and developed through responsible innovation," said Marshall Perkins, CEO of Medical Care Technologies "We are encouraged by the progress while continuing our commitment to rigorous testing and regulatory preparedness."

The MDCE Melanoma Scan Beta platform continues to be developed as an image organization and monitoring system intended to support longitudinal skin health tracking and preventative wellness awareness. It remains in beta-stage development, has not received regulatory clearance, and is **not intended to diagnose, treat, cure, or prevent any disease or medical condition**, nor to replace professional medical advice or evaluation.

These advancements align with MDCE's diversified technology portfolio, which includes the recently overhauled corporate website at [www.medicalcaretechnologies.com](https://www.medicalcaretechnologies.com) offering Vision API services, the high-value sports memorabilia platform at InfiniteAuctions.com, and the industry-leading authentication site at www.realgameused.com.

About Medical Care Technologies, Inc.:
Medical Care Technologies, Inc. (OTC PINK:MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and advanced software development initiatives. The Company is actively developing AI-assisted imaging and computer vision technologies designed to support emerging opportunities across digital health and preventative wellness markets.

Contact Information:
Medical Care Technologies, Inc.
Website: https://medicalcaretechnologies.com/
Email: info@medicalcaretechnologies.com
Phone: 1-480-645-0750
Address: 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204

Safe Harbor Statement:
This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding product development, testing activities, future platform capabilities, commercialization opportunities, and business strategy. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc.


View the original press release on ACCESS Newswire

© Copyright 2026 ACCESS Newswire. All Rights Reserved.

MDCE??

Truly a piece of pumped up, PR driven Pinkyland pile of safe harbour protected shit.

You know it—All know it🙈

That means that the endless PR’s have no basis in reality or current related facts.

It should be apparent to all that you are actually complicit in this POS enterprise

MDCE stinks-Marshal stinks—You stink😎

Medical Care Technologies Inc. (OTC Pink:MDCE) Subsidiary Infinite Auctions Presents Kobe Bryant 2001 NBA Finals Championship Sneakers with $200,000 Buy It Now Option

Rare Dual-Signed, Photo-Matched "The Kobe 1" Sneakers from Series-Clinching 01' NBA Finals Game 5 Now Available Alongside 2009 Playoff Sneakers at $40,000 Buy It Now in Live Summer 2026 Flash Auction.

MESA, AZ / ACCESS Newswire / July 3, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that two of the most significant Kobe Bryant game-worn sneaker lots in recent years are now available in its Infinite Auctions Summer 2026 Game Used Flash Auction at https://infiniteauctions.com/auctions, currently live and running through Saturday, July 18, 2026 at 9:00 PM EST.

Both lots feature exceptional provenance, dual signatures, and ironclad photo-match authentication by MDCE's subsidiary Real Game Used (RGU) at www.realgameused.com.

Featured Kobe Bryant Lots with Buy It Now Options:

Kobe Bryant 2001 NBA Finals Game 5 Photo Matched, Dual Signed Adidas "The Kobe 1" Sneakers Matched to the series-clinching championship victory on June 15, 2001, in which Kobe delivered 26 points, 12 rebounds, and 6 assists. These sneakers are one of only two known pairs worn in the game and are accompanied by RGU Photo Match Letter of Authenticity, MEARS documentation, and JSA authentication for the signatures. Available with a $200,000 Buy It Now option until the auction closes.

Kobe Bryant 2009 WCSF Game 4 & Game 6 Photo Matched, Playoff Game Worn, Dual Signed Playoff Sneakers Authenticated with RGU MATCH LOA and worn during the intense Western Conference Semifinals series against the Houston Rockets as the Lakers advanced toward the 2009 NBA Championship. Available with a $40,000 Buy It Now option until the auction closes.

"These two Kobe Bryant sneaker lots represent defining moments in his career - from the young superstar clinching his first championship in 2001 to the prime-era playoff battles in 2009," said a spokesperson for Medical Care Technologies. "The $200,000 and $40,000 Buy It Now options reflect the exceptional rarity, provenance, and collector demand for these authenticated pieces. Serious buyers now have the opportunity to secure them immediately or compete through live bidding."

Infinite Auctions and Real Game Used operate as wholly owned subsidiaries of Medical Care Technologies Inc., delivering a fully integrated ecosystem of trusted authentication and seamless online bidding powered by proprietary in-house technology.

About Infinite Auctions InfiniteAuctions.com is a premier online platform specializing in high-value sports memorabilia auctions, offering collectors and consignors a seamless, transparent marketplace with advanced in-house technology.

About Real Game Used RealGameUsed.com is the industry leader in photo-match authentication, providing collectors with trusted, fully digital submission and verification services.

About Medical Care Technologies, Inc. Medical Care Technologies, Inc. (OTC PINK:MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and advanced software development initiatives.

Contact Information Infinite Auctions / Medical Care Technologies, Inc. Website: https://infiniteauctions.com | https://realgameused.com | https://medicalcaretechnologies.com Email: info @viniboombotz-645-0750 Address: 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204

Safe Harbor Statement This press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc.


View the original press release on ACCESS Newswire

© Copyright 2026 ACCESS Newswire. All Rights Reserved.

He is saying that current technology has made the patent obsolete and it doesn't reflect how he is currently doing business.

Does that mean that another company already possesses the patent?

In all my years trading I have never seen such remarkable will and determination by management of publishing update after update esp. since they don't lead to anything (yet). I must say I am positively impressed by this obsessive promotion despite the lack of result. The offering, may it be postponed or not, suggests no management knows about the destructive nature of an RS at the wrong time (low trips) and, accordingly, does not plan one.
I am starting to add in the 0002s. (Wont go over 30M though, have 16M)

But wait🙈—There’s more forward looking bull💩 today 😱

Just as expected🤣

Safe Harbor Statement This press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

Keep doing what you do best🤥



😱😱🙈🙈😱😱🥂

GLTU/A

Medical Care Technologies Inc. (OTC Pink:MDCE) Advances Beyond Original AI Vision Patent - Technology Has Evolved Faster Than Expected

Rapid Internal Innovation Renders U.S. Provisional Patent Application No. 63/854,935 Obsolete, Highlighting Exceptional Velocity in AI Development

MESA, AZ / ACCESS Newswire / July 2, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that it has elected not to proceed with its U.S. Provisional Patent Application No. 63/854,935, originally filed in July 2025 for its AI Vision Technology. This decision reflects the Company's accelerated pace of innovation, as its current proprietary AI vision systems and software have advanced significantly beyond the original application.

Since filing the provisional patent in July 2025, MDCE's engineering teams have achieved substantial breakthroughs in computer vision algorithms, real-time image processing, model efficiency, and practical deployment across multiple platforms. These advancements have made the 2025 provisional application outdated, as the Company's live and beta technologies now deliver superior performance and capabilities.

"Our AI vision technology and software development has progressed at a speed that surpassed even our own expectations," said Marshall Perkins, CEO of Medical Care Technologies. "Instead of pursuing an application that no longer reflects our current state-of-the-art systems, we are fully focused on deploying and protecting our next-generation solutions that are already powering real-world products and delivering strong results. This demonstrates our agility and commitment to staying far ahead of the curve."

Key current implementations of MDCE's evolved AI Vision technology include:

Vision API Services now available through the corporate website for enterprise clients

MDCE Melanoma Scan Beta platform, showing promising internal testing results

Advanced image recognition features integrated into Snapshot Recipes and RealGameUsed.com authentication workflows

This strategic decision underscores MDCE's dynamic development culture and focus on rapid commercialization of cutting-edge solutions rather than legacy filings. The Company continues to evaluate new intellectual property opportunities based on its latest innovations across AI imaging, digital wellness, and authentication technologies.

About Medical Care Technologies, Inc.

Medical Care Technologies, Inc. (OTC PINK:MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and advanced software development initiatives. The Company is actively developing AI-assisted imaging and computer vision technologies designed to support emerging opportunities across digital health, preventative wellness, and consumer applications.

Contact Information
Medical Care Technologies, Inc.
Website: https://medicalcaretechnologies.com/
Email: info@medicalcaretechnologies.com
Phone: 1-480-645-0750
Address: 1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204

Safe Harbor Statement This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding product development, intellectual property strategy, future platform capabilities, and business strategy. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc.


View the original press release on ACCESS Newswire

© Copyright 2026 ACCESS Newswire. All Rights Reserved.

Medical Care Technologies Inc. (OTC Pink:MDCE) Launches Infinite Auctions EPIC Summer 2026 Game Used Sports Auction - Bidding Opens Today

Star-Studded Lineup Featuring LeBron James, Kobe Bryant, Carmelo Anthony & Allen Iverson Headlines Premium Game-Worn Memorabilia Auction

MESA, AZ / ACCESS Newswire / July 1, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the official opening of its Infinite Auctions Summer 2026 Game Used Flash Auction. Bidding is live today, July 1, 2026, and will run through Saturday, July 18, 2026 at 9:00 PM EST.

This high-profile auction showcases an exceptional collection of authentic game-used memorabilia from NBA legends, with all items rigorously authenticated by MDCE's subsidiary Real Game Used (RGU) at www.realgameused.com, the industry leader in photo-match authentication.

Standout lots include:

LeBron James April 12, 2014 Game Used Photo Matched Miami Heat Away Jersey (NBA/MeiGray LOA) - The night he completed his record-setting 10th 25/5/5 season.

Carmelo Anthony's Final Game as a New York Knick - Game Worn Home Jersey - MeiGray Photo Matched, April 12, 2017 vs. Philadelphia 76ers at Madison Square Garden.

Kobe Bryant 2001 NBA Finals Game 5 Photo Matched, Dual Signed Adidas "The Kobe 1" Sneakers - Matched to the series-clinching championship victory with 26 points, 12 rebounds, and 6 assists.

Allen Iverson Feb. 27, 2006 Game Used Photo Matched Signed Philadelphia 76ers Road Jersey(MeiGray/RGU LOA) - Rare! Only photo-matched jersey in this style and colorway.

The auction features 58 carefully curated lots of game-used jerseys, sneakers, and memorabilia. Collectors benefit from seamless bidding, proxy options, and trusted authentication through Real Game Used (RGU).

"This Summer 2026 Flash Auction brings together elite game-worn pieces from NBA legends, all authenticated by our subsidiary Real Game Used," said a spokesperson for Medical Care Technologies. "With ironclad photo-match verification and our fully integrated in-house platforms, Infinite Auctions delivers the transparency and confidence serious collectors and investors demand."

Auction Details:

Start: Tuesday, July 1, 2026 - Bidding Now Open

End: Saturday, July 18, 2026 at 9:00 PM EST

Auction Link: https://infiniteauctions.com/auctions

Infinite Auctions and Real Game Used are both wholly owned subsidiaries of Medical Care Technologies Inc., offering collectors a fully integrated ecosystem for authentication and auction.

About Infinite Auctions InfiniteAuctions.com is a premier online platform specializing in high-value sports memorabilia auctions.

About Real Game Used RealGameUsed.com is the industry leader in photo-match authentication, providing collectors with trusted, fully digital submission and verification services.

About Medical Care Technologies, Inc. Medical Care Technologies, Inc. (OTC PINK:MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and advanced software development initiatives.

Contact Information
Infinite Auctions
Medical Care Technologies, Inc.
Website: https://infiniteauctions.com | https://realgameused.com | https://medicalcaretechnologies.com
Email: info@infiniteauctions.com | info@medicalcaretechnologies.com
Phone: 1-480-645-0750
Address: 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204

Safe Harbor Statement This press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc.


View the original press release on ACCESS Newswire

© Copyright 2026 ACCESS Newswire. All Rights Reserved.

But wait🙈—There’s more bull💩 today😱



Safe Harbor Statement This press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

https://investorshub.advfn.com/stock-market/USOTC/medical-care-technologies-id-MDCE/stock-news/98847153/medical-care-technologies-inc-otc-pink-mdce-launc

Can’t speak logic to Marshall. Look how well he’s done so far….

Now knock down the subscription price to the $1.99 range.   Getting people familiar with the company is the top priority right now.....or should be 

Cool. More app news

Medical Care Technologies Inc. (OTC PINK:MDCE) Rolls Out Visually Stunning Super-Charged Version of Snapshot Recipes Mobile App

Photograph Your Open Refrigerator for Instant Personalized Recipes - Faster, More Beautiful and Built for Scale

MESA, AZ / ACCESS Newswire / June 30, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a comprehensive redesign and upgrade to its flagship consumer wellness app, Snapshot Recipes, transforming it into a visually stunning, high-speed AI culinary powerhouse. Learn more about the app at https://snapshotrecipes.app.

The complete visual overhaul introduces a bold, artistic, and modern creative design that elevates the user experience with mouth-watering imagery, intuitive navigation, and immersive aesthetics. Paired with significantly faster recipe generation speeds and a massively expanded library spanning all major food and drink categories (appetizers, entrees, desserts, global cuisines, healthy options, cocktails, mocktails, and more), Snapshot Recipes is now more engaging and powerful than ever.

Game-Changing 'Open Fridge' Feature Takes Center Stage

Users simply take a photo of their open refrigerator (or pantry, groceries, leftovers, or any plated meal) and receive instant, personalized chef-quality recipes based on what they already have. Additional inputs include typing ingredients, describing cravings, or uploading photos/screenshots - delivering results in seconds.

To accelerate user growth and engagement, the Company has hired a full-time social media manager dedicated exclusively to Snapshot Recipes. Additionally, MDCE is actively meeting with top advertising agencies to launch a major digital marketing campaign focused on high-conversion strategies designed to drive clicks, downloads, and user acquisition at scale.

"This is more than a redesign - it's a strategic leap forward in consumer experience and go-to-market execution," said Marshall Perkins, CEO of Medical Care Technologies. "With the breathtaking new artistic interface, faster AI performance, vast recipe library, dedicated social media leadership, and an upcoming high-impact digital marketing push, Snapshot Recipes is perfectly positioned to capture significant market share in the AI wellness and recipe space while delivering strong user growth and recurring revenue."

Key enhancements include:

Stunning New Artistic Visual Appeal - Cinematic, food-porn style design that makes every recipe irresistible.

Faster AI Recipe Generation - Near-instant results for seamless everyday use.

Massively Expanded Recipe Library - Broader coverage across 30+ global cuisines, beverages, and specialized dietary needs with full nutrition facts (calories, macros, micronutrients).

Smart Features - Intelligent cookbook organization, shareable grocery lists, and personalized recommendations.

Snapshot Recipes is available now on the Apple App Store and Google Play, currently offering a first month free promotion.

This update underscores MDCE's commitment to scalable consumer AI platforms that complement its broader portfolio in imaging, authentication, and digital services.

About Snapshot Recipes

Snapshot Recipes is an innovative AI-powered mobile app that turns photos of open refrigerators, groceries, ingredients or meals into personalized recipes across 30+ global cuisines. It features smart ingredient detection, complete nutrition information, an intelligent cookbook, and shareable grocery lists.

About Medical Care Technologies, Inc.

Medical Care Technologies, Inc. (OTC PINK:MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and advanced software development initiatives.

Contact Information
Medical Care Technologies, Inc.
Website: https://medicalcaretechnologies.com/ | https://www.snapshotrecipes.app
Email: info@medicalcaretechnologies.com
Phone: 1-480-645-0750
Address: 1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204

Safe Harbor Statement This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding product development, marketing initiatives, future platform capabilities, and business strategy. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc.


View the original press release on ACCESS Newswire

© Copyright 2026 ACCESS Newswire. All Rights Reserved.

Please don’t come here spewing truth lol

MDCE has to be one of the biggest pieces of crap with daily excessives PRs and it goes nowhere. Over 800 million shares added in less than a year.

Infinite Auctions Presents the LeBron James Game Jersey That Cemented His Legacy as the Most Complete Player in NBA History

The Night LeBron Completed His 10th Consecutive 25/5/5 Season - Surpassing Oscar Robertson's Record of 9, with Jordan and Kobe at 8.

MESA, AZ / ACCESS Newswire / June 29, 2026 / Infinite Auctions, a wholly owned subsidiary of Medical Care Technologies Inc. (OTC PINK:MDCE), is excited to feature one of the most historically significant LeBron James game-used jerseys ever to hit the auction market. Bidding opens July 1st at https://infiniteauctions.com for the photo-matched Miami Heat away jersey worn by LeBron James on April 12, 2014 - the exact night he completed his record-setting 10th NBA regular season averaging at least 25 points, 5 rebounds, and 5 assists, surpassing Oscar Robertson's legendary mark of nine such seasons.

In this final regular-season game played during the 2013-14 campaign, LeBron posted a game-high 27 points, 8 rebounds, and 5 assists as the Miami Heat fell to the Atlanta Hawks in a 98-85 contest. The black away jersey - complete with tackle-twill lettering and numbering, NBA Logoman patch, Adidas "2XL" tag with "LENGTH +2" flag, "EVERY PLAYER. EVERY GAME." tag, serial number "MHE 02129," and "4.12.14" handwritten in ink - captures one of the most defining statistical milestones of LeBron's career.

Conclusively photo-matched by MeiGray (NBA/MeiGray LOA MHE02129) and accompanied by an official NBA Letter of Authenticity, this jersey was sourced directly from NBA Auctions in 2014. In the wake of the well-publicized Miami Heat memorabilia heist, legally sourced, fully authenticated LeBron James Miami Heat game-worn memorabilia commands a significant premium among serious collectors and investors.

Why This Jersey is a Must-Have for High-End Collectors and Alternative Asset Investors:

Unparalleled Statistical Dominance: LeBron has achieved the elite 25/5/5 stat line in 20 consecutive seasons - compared to just 8 seasons each for Michael Jordan and Kobe Bryant across their entire careers.
Ironclad Authentication: MeiGray photo-match + official NBA Letter of Authenticity from direct NBA Auctions provenance.
Attractive Acquisition Opportunity: Starting bid of $7,500 with a $110,000 Buy It Now option available for the duration of the auction.
Investment-Grade Opportunity: Blue-chip, photo-matched superstar jerseys from milestone games continue to deliver strong appreciation as tangible alternative assets.
Elite Condition: Pristine game-worn attributes from LeBron's dominant Miami Heat era.

Bidding opens July 1st as part of Infinite Auctions' major summer auction featuring hundreds of thousands of dollars in premium sports memorabilia. Register and bid at: https://infiniteauctions.com

"This jersey immortalizes the night LeBron James statistically redefined all-around greatness in the NBA," said Marshall Perkins, CEO of Infinite Auctions. "For high-end collectors and investors seeking rare, provenance-rich alternative assets, this record-breaking LeBron James jersey represents a generational opportunity."

About Infinite Auctions InfiniteAuctions.com is a premier online platform specializing in high-value sports memorabilia auctions, delivering transparency, convenience, and exceptional experiences for consignors and collectors worldwide.

About Medical Care Technologies, Inc. Medical Care Technologies, Inc. (OTC PINK:MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and advanced software development initiatives.

Contact Information Infinite Auctions / Medical Care Technologies, Inc. Website: https://infiniteauctions.com | https://medicalcaretechnologies.com Email: info @viniboombotz-645-0750 Address: 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204

Safe Harbor Statement This press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Infinite Auctions / Medical Care Technologies Inc.


View the original press release on ACCESS Newswire

https://app.accessnewswire.com/img.ashx?id=1182187

© Copyright 2026 ACCESS Newswire. All Rights Reserved.

🙈🤧https://investorshub.advfn.com/stock-market/USOTC/medical-care-technologies-id-MDCE/stock-news/98817229/medical-care-technologies-inc-otc-pink-mdce-anno

🤫🤣

GLTA✌️

The answer to the “who’s buying” joke is: “well, the conglomerate corporations of course, with the loads of free money the government doles to them.

MDCE needs some.

Marshall, notice your Form 1-A/A says Kaplan owned no shares as of September 30, 2025. (really, that he’s not a 5% or greater shareholder)

And likewise, your 2025 Q3 says Kaplan bought 1.3B shares in 2025, but by the end of Q3 2025 Kaplan generally owned zero or at maximum under 5% of MDCE shares. Not a 5% or greater shareholder.

Then your 2025 Annual Report (inclusive of Q4) says Kaplan bought about 800M shares in Q4 2025, and that Kaplan owns over 2.1B MDCE shares. — Showing he did not sell any nor did he sell down to owning zero shares by end of 2025-Q3, as the 2025 Q3 says he did.

Your 2026 Q1 also says Kaplan owns over 2.1B MDCE shares. — Showing Kaplan did not sell any nor did he sell down to owning zero shares by end of 2025-Q3, as the 2025 Q3 says he did.


You also just announced Kaplan owns zero MDCE shares, hence your 2026 Q1 cannot be correct.

So that’s the 2025 Q3 filing incorrect, if the Annual Report is correct.

And so also, that’s the 2025 Q3 filing incorrect, if the 2026 Q1 is correct.

But you now claim Kaplan owns no shares thus making your 2026 Q1 incorrect. Insufficient trade volume has occurred since end of 2026 Q1 for Kaplan to have sold 2.1B MDCE shares.

And so, likely making your 2024 Q4/Annual Report incorrect too.

Yikes!

Right?

It is exhausting, you’re right there.

——

Further, a 65.2% share owner of a company is without doubt an affiliate of the company. An affiliate’s shares are always control shares. Whether acquired as registered or non-registered shares, an affiliate’s control shares are always subject to Rule 144 re-sale restrictions because when selling shares an affiliate of the company is always considered an issuer. Always.

https://clsbluesky.law.columbia.edu/2014/01/14/restricted-securities-vs-control-securities-what-are-the-differences/

.

How many outstanding does ENCZ have? As in comparison to MDCE ? And, MDCE expects to max to it authorized limit?

Here is the bottom line issue......share price is beyond stagnant.   No value here for quite some time.
Example, $ENCZ was a giant failure and scam, but it has a share price 5 times higher than $MDCE.   Why do people look at this as worse investment that that?????
Do better Marshall. 

Respectfully (even though undeserved)

You are the poster boy for a Father Time certified bloviating, self aggrandizing Pinkyland CEO self enriching POS🙈

Please—Carry on🙈



Have a good weekend✌️

You have stated Kaplan has 0 shares since Jan. I get it. Yet the latest filing May 11 includes the 2.1 B+ shares in the table of shares and the statement below in bold, please put out a corrected filing. Also have someone verify the filings before release, this is public company 101 stuff and what investors use to determine investability.

Thanks for what your building, it is night and day different from a year ago. Some of us have noticed and appreciate the huge effort.

:Longside
Ventures (Ben
Kaplan)
5%+ Peoria, AZ 2,119,038,496 Common 65.20 %


GLTAL

If you really raised that much in the last two months, then why did you just recently reduce the price of the Reg A from .00013 (April 2026) to .00006 (June 2026)? 
That looks desperate, deliberate, and not just an ace in the hole. 
For someone not needing cash, you are willing to sell half the company for $266k. 
From an investor’s point of view that means one thing. You mean to dilute and then just do a reverse split. IMO of course. There’s no other way about this. It’s literally in the stinky OTC CEO handbook that scam CEO’s pass between each other. 
You say you’re not, but those are just words. You prove the “bashers” right almost daily with your actions, not your vague PR words. 
If you don’t need the Reg A…. Then cancel it, reduce the AS and watch this move. But since you’re a greedy fool, you won’t do it and then you will just insult every single investor you have. 
How many positive investors are left?

So Marshall i’m a mixed bag because yea you are leaps and bounds ahead of where you were.
The problem is that the pps has been based at .0002 since you last sold on the REG A and in 7 months done nothing to help share price for shareholders. In fact the volume and liquidity has dried up with every PR and there has been a lot. That’s not normal for a company going places and building value for shareholders. 
“ To clarify, the current Regulation A is a contingency financing tool—not our primary operating strategy”“To clarify, the current Regulation A is a contingency financing tool—not our primary operating strategy”
There are a lot of people who have been here for years praying and hoping for your success but with every update it becomes a bigger mess.
Many have asked to help make it make sense but we are at a point that a spade is a spade. 
Either wow us with shareholder value and intent or just sell the shell because this is dead in the water and no one is buying it. 

Could go with your bullshit easee, but Marshall clarified today. Howdya like that timing. I’ve been correct the entire time. You been fighting it. Calling it something else. Now Marshall clarifies and announces it today, and you say “good news!” LOL! Opposite of your responses to me.
Reading the filings and logical deduction. Compare to making-up a half story and calling it real, ignoring what’s real, ignoring facts presented, as you do and sell to folks daily. It was evident that Marshall expected Kaplan to have sold near all and that therefore the 2026 Q1 is incorrect and is misinformation. Flipping likely was pre-established as communicated as part of their Reg-A funding and share issue arrangement. Marshall thinks it’s just the way it’s done. He just doesn’t know. Kind of innocent or oblivious to nuances of regulations. I think he’s a good guy.
Owning 65% of a company makes that person an affiliate of the company. An affiliate who owns control securities. Control securities owned by an affiliate are always subject to Rule 144. Rule 144 mandates sales limitations. The dribble rule. Kaplan didn’t, he flipped.
Have a good night.

Answering questions is not pumping.

There's a third thing worse than those two: A Principal pumping his own stock on a message board.

We appreciate the candid feedback and understand the concerns. To clarify, the current Regulation A is a contingency financing tool—not our primary operating strategy as we have raised more than the entire Reg A raise amount with non-dilutive capital generation in just 2 months. Our immediate focus remains on building shareholder value through revenue growth, non-dilutive capital generation, strategic asset monetization, and execution across our operating subsidiaries. If you believe we are doing great things as a company I’d love to answer questions about our milestones and major accomplishments if that is of any importance to you. If the only thing that matters to you is today’s share price then I can accept that as well and just know that I do not control the market. There has been almost 7 months since any shares were sold related to a Reg A and the company is miles ahead compared to 1 year ago and that’s a fact.

I truly appreciate your attention to filings. However, the obsession with Kaplan’s past shares is exhausting. He owns ZERO shares as of June 25, 2026 and of course he didn’t sell 2.3B shares over the last 30 days........... If there was an error email it to me and I will forward it to legal to ensure accuracy moving forward. Thank you.........

Great news. Please put out a filing and tell us where the 2.3B Kaplans shares that were listed in May went. The first qtr filing released in early May included in the table of shares 2.3B. It also listed Kaplan as a greater than 5% owner with the number of shares held. He didn't sell thru the market 2.3B shares in the last 30+ days. Sometimes I wonder if you even review the filings for accuracy. Thanks for what your doing, but please verify the filing info and SS. I have commented on this multiple times, direct to you, it does not seem to be getting better.


GLTAL

REALISTICALLY;

The endless repetitive “headlines” are spewed out by you like endless diarrhea almost daily 🙈

It’s right out of the Pinkyland ceo handbook😁

Applying for the second Reg A on the heels of the 1st Reg A was like nailing your own coffin. Whoever thought that was a good idea to help get things moving on the cusp of all the news flow clearly doesn’t understand the current landscape in the OTC - might need to rethink counsel. 
A Reg as that opens up the OS to being maxed means nothing but dilution and screwing over investors here.
You clearly don’t understand the symbiotic relationship that is needed to bring cash flow through an otc company. 
It’s really disappointing because the potential for some of what you are working on is in a good space. 
Unsolicited QuotesDifficulty getting clean info on corporate structureDifficulty in getting info on company, employees, contractors, consultantsZero Price ActionNo liquidity2nd Reg A looming that will obliterate investors
Seriously why should anyone buy this here???
Yes I know you’re building something special here but there is absolutely nothing that is being built for shareholders because the plan in itself does nothing for them.

Personal attacks from a Pinkyland ceo are always expected when called out for related bullshit.

Thanks for the confirmation once again🙈

Have a good night✌️

Funny talk coming from a guy that took a company from .03 to .00002 and now has a Reg A out selling shares at .00006…..

Absolutely! We make headlines regularly. When you learn to read you should check them out.

Something we agree about. It has been loud as it killed this stock. And don’t think buying will come with that lingering over this stock. 

More PR’s please🙈

TiA

We applied for the Reg A as an ace in the hole as the regulatory roadmap has different layers of expenses as we move forward with our wellness applications. Our first Reg A took over 6 months for approval. We applied not thinking it would be approved in 2 business days. I would have really preferred being approved later as its approval has become louder than our company accomplishments.

If the “company” is doing so well, why do another Reg A and absolutely kill shareholder interest?? 

Great! We haven’t sold any shares into this current Reg A as of today June 25, 2026. We have raised a considerable amount of non-dilutive capital through selling company assets through Infinite Auctions and will continue to do so. Ben Kaplan hasn’t had shares for a while. The most egregious MDCE misinformation is born on this message board. If you want factual information just reach out. Someone across the country on their couch does not know more about MDCE than the company does. You guys all bash consecutively like there’s one person who owns 3 basher accounts on this board. This is obvious. I rarely have time to babysit lies and negativity. If you want facts follow us on X.com.

Exactly as expected from a 🤥 Pinkyland ceo🙈



Be well🥂

Good news Marshall, stock is at .0002. You can buy now and just sell at .0003.